Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis

Atherosclerotic heart disease is the leading cause of mortality and morbidity in the USA. Low density lipoprotein (LDL) has been the target for many hypolipidemic agents to modify atherosclerotic risk. Bempedoic acid is a novel hypolipidemic drug that inhibits the enzymatic activity of ATP citrate l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tummala, Ramyashree, Gupta, Manasvi, Devanabanda, Arvind Reddy, Bandyopadhyay, Dhrubajyoti, Aronow, Wilbert S., Ray, Kausik K., Mamas, Mamas, Ghosh, Raktim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Cardiology & Cardiovascular Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090378/
https://www.ncbi.nlm.nih.gov/pubmed/35533049
http://dx.doi.org/10.1080/07853890.2022.2059559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090378/
https://www.ncbi.nlm.nih.gov/pubmed/35533049
http://dx.doi.org/10.1080/07853890.2022.2059559

Ejemplares similares